Is Computer-Aided Detection Good for Screening Mammography?
Women's Health Summary and Comment
Free
CAD seemed to raise mammography recall rate in a U.K. study, but the implications for U.S. practice are unclear.
Is Computer-Aided Detection Good for Screening Mammography?
CAD seemed to raise mammography recall rate in a U.K. study, but the implications for U.S. practice are unclear.
Minimizing Bone Loss Related to Therapy with Aromatase Inhibitors
Oncology and Hematology Summary and Comment
Free
Denosumab seemed protective against AI-induced bone loss in women with early-stage breast cancer.
Maintaining Bone Mass in Premenopausal Breast Cancer Patients: How Effective Is Zoledronic Acid?
Women's Health Summary and Comment
IV bisphosphonate provided long-term protection against BMD loss in premenopausal women receiving adjuvant endocrine therapy.
Prophylactic Mastectomy’s Psychological Aftermath
Women's Health Summary and Comment
Swedish investigators found changes in reported sexuality and body image and a substantial drop in anxiety at 1 year after prophylactic mastectomy.
By Andrew M. Kaunitz, MD
September 25, 2008
Covering:
Brandberg Y et al., J Clin Oncol 2008 Aug 20; 26:3943
Aromatase Inhibitors and Joint Symptoms: Who Is at Risk?
Women's Health Summary and Comment
Risk factors for incident arthralgias included use of an AI, prior hormone therapy or chemotherapy, and hormone-receptor–positive tumors.
Insights from a Negative Result
Not all taxane-containing adjuvant regimens are equivalent, and some node-positive breast cancer patients with low gene-assay–based recurrence scores might do well with endocrine therapy alone.
By William J. Gradishar, MD
September 16, 2008
Covering:
Goldstein LJ et al., J Clin Oncol 2008 Sep 1; 26:4092
Goldstein LJ et al., J Clin Oncol 2008 Sep 1; 26:4063
Paik S et al., J Clin Oncol 2008 Sep 1; 26:4058
Recertification Scores Correlate with Quality of Care
Dermatology Summary and Comment
Some indicators of quality of care were positively associated with top scores on the internal medicine recertification exam.
By Jeffrey P. Callen, MD
September 5, 2008
Covering:
Holmboe ES et al., Arch Intern Med 2008 Jul 14; 168:1396
Landon BE., Arch Intern Med 2008 Jul 14; 168:1365
LNG IUS Safe for Breast Cancer Patients
Women's Health Summary and Comment
Recurrence rates were not significantly higher in women using LNG IUS after treatment for breast cancer than in similar patients who did not use the system.
Do Women Complete Radiation Therapy for Breast Cancer?
Women's Health Summary and Comment
Despite high overall rates of completion, some women did not finish their XRT.
